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Abstract
Purpose: To evaluate PTV margins for hypofractionated IGRT of prostate comparing kV/kV imaging or CBCT.
Patients and methods: Between 2009 and 2012, 20 patients with low- (LR), intermediate- (IR) and high-risk (HR)
prostate cancer were treated with VMAT in supine position with fiducial markers (FM), endorectal balloon (ERB) and
full bladder. CBCT’s and kV/kV imaging were performed before and additional CBCT’s after treatment assessing
intra-fraction motion. CTVP for 5 patients with LR and CTVPSV for 5 patients with IR/HR prostate cancer were
contoured independently by 3 radiation oncologists using MRI. The van Hark formula (PTV margin =2.5Σ +0.7σ)
was applied to calculate PTV margins of prostate/seminal vesicles (P/PSV) using CBCT or FM.
Results: 172 and 52 CBCTs before and after RT and 507 kV/kV images before RT were analysed. Differences
between FM in CBCT or in planar kV image pairs were below 1 mm. Accounting for both random and systematic
uncertainties anisotropic PTV margins were 5-8 mm for P (LR) and 6-11 mm for PSV (IR/HR). Random uncertainties
like intra-fraction and inter-fraction (setup) uncertainties were of similar magnitude (0.9-1.4 mm). Largest uncertainty
was introduced by CTV delineation (LR: 1-2 mm, IR/HR: 1.6-3.5 mm). Patient positioning using bone matching or
ERB-matching resulted in larger PTV margins.
Conclusions: For IGRT CBCT or kV/kV-image pairs with FM are interchangeable in respect of accuracy. Especially for
hypofractionated RT, PTV margins can be kept in the range of 5 mm or below if stringent daily IGRT, ideally
including prostate tracking, is applied. MR-based CTV delineation optimization is recommended.
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Background
Image-guided radiation therapy (IGRT) is the preferred
method for curative treatment of localized prostate
cancer and is associated with improved outcome and
reduced toxicity [1]. IGRT using cone-beam computed
tomography (CBCT) or kilovoltage (kV/kV) gold fiducial
marker (FM) imaging in combination with conformal
radiation therapy (RT) techniques such as intensity-
modulated radiotherapy (IMRT) or volumetric modulated
arc therapy (VMAT) potentially allow smaller treatment
margins and to escalate dose to the prostate [2].
PTV margins have been reduced from 10 mm in the
pre-IGRT-era to 3-5 mm in the IGRT-era [3,4]. There is
little consensus on the magnitude of PTV margin for RT
of the prostate mainly due to inter-institutional technical
issues and the preferred IGRT modality [5].
To compute the magnitude of a PTV-margin that
allows the CTV receive the prescribed dose with a
clinically acceptable and specified probability, statistics
of all uncertainties in the treatment process chain
should be known [6,7]. Geometrical uncertainties in
RT include both treatment preparation variations and
execution uncertainties. They both can be systematic such
* Correspondence: daniel.zwahlen@gmx.ch
†Equal contributors
1Department of Radiation Oncology, University Hospital Zurich, Zurich,
Switzerland
2Department of Radiation Oncology, Hospital Graubuenden, Chur,
Switzerland
© 2014 Oehler et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Oehler et al. Radiation Oncology 2014, 9:229
http://www.ro-journal.com/content/9/1/229
as equipment maladjustments, planning setup uncertain-
ties, and target volume delineation or random such as
treatment setup uncertainties, inter- and intra-fraction
organ motion [7].
The aim of this work was to investigate PTV margin
determination in the IGRT-era with endorectal balloon
(ERB) calculating systematic and random treatment
uncertainties. Furthermore, the IGRT modalities CBCT
and kV/kV FM imaging were compared with each other
in the context of PTV margin determination.
Patients and methods
Study design and patient selection
From January 2009 to April 2012, 20 non-consecutive
patients with histologically proven low- (LR), intermediate-
(IR) or high-risk (HR) adenocarcinoma of the prostate
were treated according to the CHHIP (Conventional
or Hypofractionated High Dose Intensity Modulated
Radiotherapy for Prostate Cancer) protocol [8], and
according to randomization VMAT (RapidArc®) was used
to a dose of 74Gy/37f (n = 14), 60Gy/20f (n = 1) or 57Gy/
19f (n = 5) at the University Hospital Zürich, Switzerland
[9]. Hypofractionation schedules were used only for
patients randomized within the CHHIP trial (open
between 2010 and 2011 at Zurich) and not off-study,
since hypofractionation was not standard at that time.
Planning CT scans, kV/kV images and CBCT’s of the
20 patients were retrospectively analysed with ethics
approval (Department of Radiation Oncology, University
Hospital Zurich).
Figure 1 Depiction of the mean differences in vertical, lateral and longitudinal directions between the intersections (blue) and the
unions (pink) of the three CTVp as contoured by three radiation oncologists. The prostate volume was divided into 6 subsections (anterior,
posterior, left, right, cranial, caudal).
Table 1 Systematic Σ and random σ setup error depending
on surrogate used for matching kV/kV images to the
reference CT
Σ (mm) σ (mm)
Bones vrt 1.78 1.97
lng 1.39 2.30
lat 0.77 0.85
Balloon vrt 1.53 1.36
lng 3.20 3.15
lat 1.70 1.35
FM vrt 0.88 0.71
lng 1.16 0.46
lat 0.46 0.37
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Target definition and treatment planning
Two weeks prior to CT simulations, 3 FM were placed
into the prostate under rectal ultrasound guidance.
Non-contrasted planning CT simulation with axial
slices thicknesses of 2.0 mm was performed in supine
position by use of a leg holder immobilization device,
empty rectum with endorectal balloon (ERB) and full
bladder. Reference points were tattooed on the skin.
CTV was defined as prostate (P) only for LR, prostate
plus 1/3 of the seminal vesicles (PSV) for IR or the prostate
plus the seminal vesicles for HR cancer patients. In order to
evaluate the delineation error of prostate only or prostate/
seminal vesicles, the CTVP for 5 pts with LR and
CTVPSV for 5 pts with HR prostate cancer were contoured
independently by 3 experienced radiation oncologists
using non fused MR images with rectal coil. No formal
contouring training was performed.
Treatment
Daily localization of the prostate position was performed
using FM before treatment. CBCT was performed on day
1 to 3, then once every week (hypofractionation: 6 × 6
CBCT, normofractionation: 14 × 9-10 CBCT). Additional
in-between CBCT were not used for evaluation. For 10
patients (57Gy/19f (n = 1), 74Gy/37f (n = 9)) an additional
CBCT was performed after each fraction to assess intra-
fractional motion once a week (1 × 4 CBCT, 9 × 7 CBCT).
Due to patient’s distress, failure of CBCT or correlation
function, not all post-treatment CBCT could be used for
evaluation. On day 1 the isocenter after CBCT based
corrections was marked on the patient skin. Online
isocenter positioning was performed based on FM using
CBCT – as indicated above - or kV image pairs. kV/kV
images were performed before each fraction except when
a weekly or in-between CBCT was applied. On days
with post-treatment CBCT a kV/kV image pair was per-
formed for comparison reason (14 × 37 kV/kV +5 ×
19 kV/kV +1 × 20 kV/kV =633 kV/kV – 172 kV/kV
(pre-CBCT days) +67 kV/kV (post-CBCT days) =528 kV/
kV – 21 kV/kV (in-between CBCT) =507 kV/kV).
Statistical analysis
The van Herk formula M =2.5Σ +0.7σ was used for PTV
margin calculation, where Σ represents the systematic
and σ the random uncertainty. Random uncertainties are
statistical fluctuations whereas systematic uncertainties
are often due to a problem which persists throughout the
entire treatment. We calculated systematic uncertainty for
intra-fractional motion, contouring as well as setup.
Random uncertainties were calculated for intra-fractional
motion and patient setup. Total Σ was then calculated:
Σ = (Σ2contour + Σ
2
patient setup + Σ
2
intrafraction motion)
1/2 as well as
total σ: σ = (σ2patient setup + σ
2
intrafraction motion)
1/2. Statistical
analysis was performed with MATLAB, version 11
(Mathworks, MA, U.S.A.). We used a σp – where σp is the
standard deviation of the normal dose penumbra - of
3 mm assuming the worst case (cranial-caudal direction)
Table 2 Systematic Σ and random σ setup error
depending on surrogate used for matching the CBCT to
the reference CT
Σ (mm) σ (mm)
Bones vrt 1.92 1.87
lng 1.72 1.69
lat 0.61 0.90
Balloon vrt 1.68 1.82
lng 1.20 1.66
Soft tissue vrt 0.77 1.09
lng 0.36 0.17
0.49 0.93
Fiducial marker matching in CBCT was taken as a reference.
Figure 2 Bar diagram of differences in vertical (vrt), longitudinal (lng) and lateral (lat) direction between CBCT and kV/kV setup
matching on fiducial markers (N =10).
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because for VMAT σp is larger in the left/right as
well as anterior/posterior direction compared to the
cranial/caudal direction. Furthermore, changing the σp
influences only the random error and results in a
small change of the margin.
The online match was based on FM. Additionally
offline matches based on bony anatomy and ERB (kV/kV
image pairs and CBCT), as well as soft prostate tissue
(CBCT) were performed to compare different matching
techniques. The setup uncertainty was calculated for each
of the different matching techniques in respect to the
online performed FM match. To assess the difference
between FM match in kV image pairs and CBCT the two
imaging modalities were performed strictly consecutively
and shifts were compared. To assess intra-fraction
prostate motion, differences between FM position in
pre-treatment and post-treatment CBCTs were established.
The contouring uncertainties of the CTVP and the
CTVPSV were determined by comparing intersection
and union of 2 corresponding contours using a self-
developed analysis script in Matlab (Mathworks): The
prostate volume was divided into 6 subsections (anterior,
posterior, left, right, cranial and caudal) (Figure 1). For
each subsection the mean distance between the union and
the intersection was calculated. The mean and standard
deviation (SD) between the pairwise comparisons were
calculated. Wilcoxon-Mann-Whitney-Test was used to
compare contouring uncertainties for P and PSV.
Results
Setup (inter-fractional) uncertainty
172 and 52 CBCT before and after RT and 507 kV/kV
images before RT were analyzed. The setup uncertainty
was calculated for the matching on different surrogates
in kV images pairs as well as CBCT using CBCT FM
match as reference. The mean systematic and random
setup uncertainties for each modality are shown in
Tables 1 and 2. The difference in setup using FM between
CBCT and kV/kV was usually below 2 mm (Figure 2).
Matching on FM in kV/kV images or matching on soft
tissue in CBCT lead to systematic and random uncertain-
ties below 1 mm. Bony anatomy match as well as balloon
match increased the systematic as well as the random
uncertainty. This was more pronounced if kV/kV image
pairs were used compared to the use of CBCT. Large
systematic as well as random uncertainties in longitudinal
direction were found with the use of the ERB as a
surrogate for prostate position since reproducible placing
of the ERB was not possible.
Intra-fractional motion uncertainty
For intra-fractional motion uncertainty calculation of
the prostate FM shift of pre- and post-treatment CBCT’s
were compared with each other (time between 3 to
6 min). Maximum FM shifts reached 5 mm in vertical
and 8 mm in longitudinal direction (Figure 3). The
systematic intra-fractional uncertainty was 1.39 mm
(vrt), 1.36 mm (lng), 0.92 mm (lat) and the day to
day random uncertainty was 1.62 mm (vrt), 1.39 mm
(lng), 0.97 mm (lat), respectively.
Figure 3 Bar diagram of intra-fraction motion in vertical (vrt), longitudinal (lng) and lateral (lat) direction during treatment (N =10).
Intra-fraction motion was determined by fiducial marker difference between pre- and post- CBCT.
Table 3 Average contouring errors for prostate (P) or
prostate with seminal vesicles (PSV) in anterior (vrt/
anterior), posterior (vrt/posterior), longitudinal (long)
and lateral (lat) direction
P (mm) PSV (mm)
vrt 1.52 2.57
vrt/anterior 1.98 3.49
vrt/posterior 1.04 1.58
Long 2.03 3.20
Lat 1.68 2.52
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Contouring error
Systematic contouring uncertainties were larger for PSV
than for P (p =0.012). The mean systematic uncertainty
was largest in the longitudinal axis as shown in Table 3.
In vertical direction the uncertainty was found to be
larger in anterior (1.98 mm (P), 3.49 mm (PSV)) than
posterior (1.04 mm (P), 1.58 mm (PSV) direction.
PTV margin (according to van Herk formula)
The calculated PTV margins can be found in Tables 4
and 5. The margin for P only was calculated to be 7.2 mm
in anterior, 5.5 mm posterior, 7.1 mm longitudinal, and
5.5 mm in lateral direction. PTV margins were larger for
PSV volumes than for P only volumes due to the contouring
differences. The difference was largest in longitudinal
direction (2.5 mm). The contouring uncertainty contributed
most to the PTV margin compared with the intra-fractional
and setup uncertainties. Matching on soft tissue in the
CBCT or on FM in kV/kV image pairs increased the
margin by less than 0.7 mm. Matching on the ERB
required an additional margin of up to 5.4 mm.
Discussion
In the IMRT-IGRT-era, PTV margin determination has
become of crucial importance [3,10]. We found a PTV
margin between 5-8 mm for the P (LR) and between
6-11 mm for the PSV (IR/HR). A similar prostate
PTV margin of 7 mm was determined by van Herk
and colleagues though intra-fractional motion was not
considered in their calculation and no ERB was used
[11]. PTV margins used at the institution based on
the CHHIP protocol and were 1 cm in all directions
for PTV1 (PSV), 1 cm/5 mm (posterior) for PTV2 (P)
and 5 mm/0 mm (posterior) for PTV3 (P) managing
the risk of rectal toxicity [8]. However use of IGRT
was not required to compensate for organ motion. We
found that random errors produced by intra-fraction
(organ motion) and inter-fraction (setup) uncertainties
were of similar magnitude. Interestingly, the largest
uncertainty was introduced by CTV delineation (LR
PC: 1 - 2 mm, IR/HR PC: 1.6 - 3.5 mm). Patient positioning
like bone or ERB matching resulted in considerably larger
PTV margins [12]. Assuming an optimal delineation error
of 1 mm our recommendations for an anisotropic PTV
margin are as follows: PTVP 6.2 mm (ant), 5.43 mm (post),
6.06 mm (lng) and 4.79 mm (lat), PTVPSV 8.03 mm
(ant), 5.81 mm (post), 7.47 mm (lng) and 6.87 mm (lat).
Application of organ tracking would allow for further
PTV lowering.
Image-guided patient positioning considerably reduced
PTV margin by about 2- 4.7 mm compared with
bone or ERB matching which is known from the
literature [10]. IGRT modalities such as CBCT and
kV/kV-image pairs with FM or CBCT soft tissue
matching were interchangeable in respect of accuracy.
While some studies have shown the same, others have
found that identification of FM on volumetric or planar
images was not equivalent (±3 mm) [5]. However, one
needs to keep in mind intra-fractional prostate motion
between imaging modalities.
In this study, the intra-fractional prostate movement
was generally below 2 mm (Σ was 0.36 – 0.75 mm) for
treatment duration of around 90 seconds, similar to
results from the literature (Σ 1-2 mm) [13]. Prolonged
RT duration can increase the intra-fractional prostate
movement up to 3-6 mm [14]. Using an ERB might
decrease intra-fractional prostate motion. Importantly,
the SV move independently from the prostate gland with
an uncertainty for PTV between 1.4 – 4.5 mm and
should be considered in future margin protocols [15].
Table 4 Margins needed to be applied for patients with low risk prostate cancer when matching on fiducial markers
(FM), soft tissue (ST), bones (B) or balloon (ERB)
M (mm) CBCT ST (mm) CBCT B (mm) CBCT Ba (mm) CBCT M (mm) kV B (mm) kV Ba (mm) kV
Anterior 7.18 7.69 9.45 9.07 7.67 8.64 8.64
Posterior 5.47 6.09 8.20 7.75 6.10 7.27 7.27
Long 7.09 7.16 9.00 8.32 7.79 12.48 12.48
Lat 5.47 5.88 5.95 6.10 5.65 7.58 7.58
Table 5 Margins needed to be applied for patients with high risk prostate cancer when matching on fiducial markers
(FM), soft tissue (ST), bones (B) or balloon (ERB)
M (mm) CBCT ST (mm) CBCT B (mm) CBCT Ba (mm) CBCT M (mm) kV B (mm) kV Ba (mm) kV
Anterior 10.52 10.94 12.28 11.99 10.88 12.18 11.62
Posterior 6.39 6.94 8.85 8.44 6.94 8.68 7.99
Long 9.67 9.72 11.23 10.71 10.19 11.24 14.23
Lat 7.39 7.76 7.80 7.95 7.53 7.88 9.11
For low risk prostate cancer patients the prostate only was treated. For high risk prostate cancer patients the prostate and the seminal vesicles were treated.
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Remarkably, the largest uncertainties for PTV margins
were produced by the radiation oncologist’s CTV
delineation, particularly in the longitudinal axis. In the
literature, the inter-observer variation for contouring
has been reported to be largest in regions near the
seminal vesicles and the apex [16]. Several geometrical
uncertainties are involved in the delineation process
including imaging resolution [6]. CTV delineation
variation can be significantly reduced using MRI,
teaching/protocols or automated model-based organ
segmentation [17].
In practice, for protocols such as RTOG 0938 trial, a
randomized phase II trial on hypofractionated radiation
therapy, PTV was defined as the CTVp plus 5 mm in all
dimensions except 3 mm posteriorly or anteriorly if
necessary [18]. However, reducing treatment margins
based on improved treatment accuracy may lead to
geographical miss and serious underdosage of the CTV
[7]. In order to prevent a geographical miss adaptive
IGRT (-2.5-4.5 mm) might be recommended with daily
imaging, especially in hypofractionation protocols [19].
The preference of IGRT modality is subject to various
considerations. In our study we have chosen FM match in
CBCT as reference since the stability of implanted markers
was shown by several studies with an average seed migra-
tion of 1.2 +/- 0.2 mm (seeds) and 0.8 mm +/- 0.6 mm
(coils) [20]. Advantages of kV/kV image pairs compared to
CBCT are reduced acquisition/matching time, imaging
dose and lower cost. However, it is an invasive procedure
with the risk for prostate infection. In our opinion, FM and
CBCT complement each other, especially in view of
adaptive and real-time tumor tracking [21].
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